SCHEDULE: BlackRock Discloses 15% Stake in Embecta Corp. Common Stock

BlackRock, Inc. has filed an amended Schedule 13G, reporting a 15.0% beneficial ownership stake in Embecta Corp.'s common stock as of June 30, 2025.

Summary

• BlackRock, Inc. reported beneficial ownership of 8,749,753 shares of Embecta Corp. common stock.
• This represents 15.0% of the total outstanding common stock of Embecta Corp.
• BlackRock holds sole voting power over 8,605,157 shares and sole dispositive power over 8,749,753 shares.
• The filing is an Amendment No. 4 to Schedule 13G, filed under Rule 13d-1(b).
• BlackRock, Inc. is classified as a parent holding company or control person.
• One of BlackRock's subsidiaries, iShares Core S&P Small-Cap ETF, holds more than five percent of Embecta Corp.'s common stock.
• BlackRock Fund Advisors, a subsidiary of BlackRock, Inc., beneficially owns 5% or greater of the outstanding shares of Embecta Corp.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. While a 13G is a factual disclosure, a large, stable stake by a prominent institutional investor like BlackRock can be viewed positively as a vote of confidence, even if it's a routine filing.

Positives

• BlackRock, a major institutional investor, maintains a significant 15.0% stake in Embecta Corp., indicating continued investment interest.
• The filing confirms that the securities are held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer.

Future Outlook

NA

Management Comments

• "To the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under 240.14a-11."

Industry Context

This filing is a standard disclosure of institutional ownership and does not provide specific industry context or trends beyond indicating BlackRock's continued investment in the healthcare or medical device sector, where Embecta Corp. operates.

Stakeholder Impact

• Shareholders: The disclosure of a significant institutional stake by BlackRock may provide a degree of stability or confidence in the stock, as it indicates a major investor's continued interest.

Key Dates

Keywords

BlackRock, Embecta Corp., Schedule 13G, Beneficial Ownership, Common Stock, Institutional Investor, Equity Stake, Investment Management